04th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180021311 | TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS | 2018-01-25 |
20180021312 | BENZOISOXAZOLE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION | 2018-01-25 |
20180021313 | Methazolamide for the treatment of cancer | 2018-01-25 |
20180021314 | THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION | 2018-01-25 |
20180021315 | METHODS OF TREATING HEARING DISORDERS | 2018-01-25 |
20180021316 | CHEMICAL COMPOUNDS | 2018-01-25 |
20180021317 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER AND METHOD USING THEREOF | 2018-01-25 |
20180021318 | PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS | 2018-01-25 |
20180021319 | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL INFECTIONS | 2018-01-25 |
20180021320 | Method of Preventing or Treating Hearing Loss | 2018-01-25 |
20180021321 | Methods of Treating Apoptosis and Altering Programmed Cell Death | 2018-01-25 |
20180021322 | 1-ARYLALKYL-4-ACYLAMINOPIPERIDINE COMPOUNDS | 2018-01-25 |
20180021323 | FLIP - A SELECTIVE MOLECULAR TARGET OF SENESCENT CELLS | 2018-01-25 |
20180021324 | ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA | 2018-01-25 |
20180021325 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | 2018-01-25 |
20180021326 | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin | 2018-01-25 |
20180021327 | TREATMENT OF CORNEAL NEOVASCULARIZATION | 2018-01-25 |
20180021328 | NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN | 2018-01-25 |
20180021329 | EXTERNAL PREPARATION COMPRISING PYRIDONECARBOXYLIC ACID DERIVATIVE | 2018-01-25 |
20180021331 | HDAC1,2 INHIBITORS AND METHODS OF USING THE SAME | 2018-01-25 |
20180021332 | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL- )QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE | 2018-01-25 |
20180021333 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EBOLA VIRUS DISEASE | 2018-01-25 |
20180021334 | USE OF ERGOT ALKALOIDS AS AN ANTHELMINTIC AGENT | 2018-01-25 |
20180021335 | HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS | 2018-01-25 |
20180021336 | IMIDAZOLIDINEDIONE DERIVATIVES | 2018-01-25 |
20180021337 | SALT OF A PYRIMIDO[6,1-A]ISOQUINOLIN-4-ONE COMPOUND | 2018-01-25 |
20180021338 | FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE | 2018-01-25 |
20180021339 | METHOD FOR TREATING LIVER DISEASES OF VARIOUS ORIGINS | 2018-01-25 |
20180021340 | METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF ABNORMAL BONE FORMATION IN A SOFT TISSUE | 2018-01-25 |
20180021341 | ACC INHIBITOR COMBINATION THERAPY FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2018-01-25 |
20180021342 | CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRI- MIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE | 2018-01-25 |
20180021343 | BURN OINTMENT FOR PROMOTING TISSUE REGENERATION AND SKIN GROWTH, AND PREPARATION METHOD THEREFOR | 2018-01-25 |
20180021344 | METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME | 2018-01-25 |
20180021345 | AUTOTAXIN INHIBITORS | 2018-01-25 |
20180021346 | NOVEL GLP-1 RECEPTOR MODULATORS | 2018-01-25 |
20180021347 | COMPOSITION FOR THE TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE | 2018-01-25 |
20180021348 | Hypotensive lipid-containing biodegradable intraocular implants and related implants | 2018-01-25 |
20180021349 | EMULSION FORMULATIONS | 2018-01-25 |
20180021350 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2018-01-25 |
20180021351 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2018-01-25 |
20180021352 | IMPLANTS AND METHODS FOR TREATING INFLAMMATION-MEDIATED CONDITIONS OF THE EYE | 2018-01-25 |
20180021353 | NUTRITIONAL INTERVENTION FOR IMPROVING MUSCULAR FUNCTION AND STRENGTH | 2018-01-25 |
20180021354 | Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor | 2018-01-25 |
20180021355 | Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease | 2018-01-25 |
20180021356 | Treating Vitamin D Insufficiency and Deficiency With 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 | 2018-01-25 |
20180021357 | METHODS FOR TREATING BACTERIAL INFECTION | 2018-01-25 |
20180021358 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-01-25 |
20180021359 | COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR | 2018-01-25 |
20180021360 | Combination Therapy Regimen For Treatment Of Selected HCV Genotypes | 2018-01-25 |
20180021361 | COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION | 2018-01-25 |
20180021362 | COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS | 2018-01-25 |
20180021363 | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | 2018-01-25 |
20180021364 | CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES | 2018-01-25 |
20180021365 | ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS | 2018-01-25 |
20180021366 | COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS | 2018-01-25 |
20180021367 | USE OF A MIXTURE OF MODIFIED GLUCOSE POLYMERS FOR REDUCING TUMOR METASTASIS | 2018-01-25 |
20180021368 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | 2018-01-25 |
20180021369 | TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES | 2018-01-25 |
20180021370 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | 2018-01-25 |
20180021371 | NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE | 2018-01-25 |
20180021372 | TREATMENT METHODS FOR DEHYDRATION USING LIPOSOMAL REHYDRATION SALT FORMULATION | 2018-01-25 |
20180021373 | Ruthenium and Indium Binding to Gastrins | 2018-01-25 |
20180021374 | Antibacterial Clay Compositions for Use as a Topical Ointment | 2018-01-25 |
20180021375 | MODIFIED BLOOD CLOTS | 2018-01-25 |
20180021376 | Naming of KH1 through KH55 good healthy cells synthesizes the KH1 through KH55 proteins | 2018-01-25 |
20180021377 | PLATELET CONCENTRATE FOR INCREASE OF CELL REGENERATION AND CELL GROWTH | 2018-01-25 |
20180021378 | METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS | 2018-01-25 |
20180021379 | METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY | 2018-01-25 |
20180021380 | COMPOSITION INCLUDING MESENCHYMAL STEM CELL DERIVED FROM ADIPOSE TISSUES AND HYALURONIC ACID DERIVATIVE, METHOD OF PREPARING THE SAME, AND METHOD OF PREVENTING OR TREATING LOW BACK PAIN USING THE SAME | 2018-01-25 |
20180021381 | ADIPOSE TISSUE-DERIVED STEM CELLS FOR VETERINARY USE | 2018-01-25 |
20180021382 | MODIFICATION OF REACTIVITY OF BONE CONSTRUCTS | 2018-01-25 |
20180021383 | PRODUCTION OF MIDBRAIN DOPAMINERGIC NEURONS AND METHODS FOR THE USE THEREOF | 2018-01-25 |
20180021384 | Method of Tissue Repair | 2018-01-25 |
20180021385 | WOUND HEALING FORMULATION | 2018-01-25 |
20180021386 | CORE-SHELL CAPSULES FOR ENCAPSULATION OF PARTICLES, COLLOIDS, AND CELLS | 2018-01-25 |
20180021387 | PROBIOTIC COMPOSITIONS AND METHODS OF USE | 2018-01-25 |
20180021388 | AVIAN FOLLISTATIN PRODUCT | 2018-01-25 |
20180021389 | SYNERGISTIC COMPOSITION COMPRISING PROPOLIS AND CARNOSIC ACID FOR USE IN THE PREVENTION AND TREATMENT OF CANDIDIASIS | 2018-01-25 |
20180021390 | PREVOTELLA HISTICOLA PREPARATIONS AND THE TREATMENT OF AUTOIMMUNE CONDITIONS | 2018-01-25 |
20180021391 | BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS | 2018-01-25 |
20180021392 | METHODS OF MODULATING IMMUNE AND INFLAMMATORY RESPONSES VIA ADMINISTRATION OF AN ALGAL BIOMASS | 2018-01-25 |
20180021393 | FUNCTIONAL FEED | 2018-01-25 |
20180021394 | ASTERISCUS GRAVEOLENS EXTRACTS AND USE THEREOF | 2018-01-25 |
20180021395 | EUCOMMIA LEAF EXTRACT, AND PREPARATION METHOD AND USE THEREOF | 2018-01-25 |
20180021396 | COMPOSITION AND METHOD FOR TREATING PRURITUS | 2018-01-25 |
20180021397 | COMPOSITIONS FOR ENHANCING BRAIN ACTIVITY | 2018-01-25 |
20180021398 | FERMENTED PENNISETUM EXTRACT | 2018-01-25 |
20180021399 | COMPOSITION AND USE THEREOF IN MANUFACTURE OF PRODUCT FOR IMPROVING INTESTINAL FUNCTION | 2018-01-25 |
20180021400 | Princess Lite | 2018-01-25 |
20180021401 | COMPOSITIONS AND METHODS FOR TREATMENT OF INTRACELLULAR DAMAGE AND BACTERIAL INFECTION | 2018-01-25 |
20180021402 | MODULATORS OF COMPLEMENT ACTIVITY | 2018-01-25 |
20180021403 | Combination Therapy | 2018-01-25 |
20180021404 | METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA | 2018-01-25 |
20180021405 | NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE | 2018-01-25 |
20180021406 | PHARMACEUTICAL REMOVAL OF VASCULAR AND/OR NEURONAL EXTENSIONS FROM A DEGENERATING DISC | 2018-01-25 |
20180021407 | TNFRSF-BINDING AGENTS AND USES THEREOF | 2018-01-25 |
20180021408 | Fusion Proteins Containing Insulin-Like Growth Factor-1 and Epidermal Growth Factor and Variants Thereof and Uses Thereof | 2018-01-25 |
20180021409 | Pharmaceutical Composition | 2018-01-25 |
20180021410 | METHODS FOR INCREASING PERFORMANCE CHARACTERISTICS IN OFFSPRING | 2018-01-25 |
20180021411 | Composition and Method for Improving Sleep Duration and Quality | 2018-01-25 |